Laleman W, Simon-Talero M, Maleux G, Perez M, Ameloot K, Soriano G, Villalba J, et al
Week one through four uses 0.25 mg, weeks five through eight use 0.5 mg, weeks nine through twelve use 1 mg, weeks thirteen through sixteen use 1.7 mg, and week seventeen onward uses the maximum of 2.4 mg
Over up to seven years of follow-up, those treated with semaglutide or tirzepatide had a 37% lower risk of developing dementia (hazard ratio [HR] 0.63, 95% CI 0.500.81), a 19% lower risk of stroke (HR 0.81, 95% CI 0.700.93), and a 30% lower risk of all-cause mortality (HR 0.70, 95% CI 0.630.78), compared to those on other antidiabetic drugs
This article will break down peptides vs semaglutide for weight loss
Carefully reintroduce foods one at a time to see which causes reactions
Can't recommend them enough!!!" "Amazing and compassionate staff